久光製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/02/22 | 4,000 | 4,014 | 3,958 | 3,973 | -32 | -0.8% | 203,300 |
| 2024/02/21 | 4,042 | 4,042 | 3,981 | 4,005 | -25 | -0.6% | 130,600 |
| 2024/02/20 | 4,036 | 4,055 | 4,020 | 4,030 | ±0 | ±0% | 119,400 |
| 2024/02/19 | 4,036 | 4,052 | 3,998 | 4,030 | -28 | -0.7% | 145,100 |
| 2024/02/16 | 4,024 | 4,076 | 3,997 | 4,058 | +84 | +2.1% | 229,400 |
| 2024/02/15 | 4,097 | 4,097 | 3,958 | 3,974 | -111 | -2.7% | 243,400 |
| 2024/02/14 | 4,130 | 4,132 | 4,040 | 4,085 | -67 | -1.6% | 179,900 |
| 2024/02/13 | 4,150 | 4,162 | 4,098 | 4,152 | +9 | +0.2% | 178,600 |
| 2024/02/09 | 4,106 | 4,162 | 4,085 | 4,143 | +7 | +0.2% | 158,900 |
| 2024/02/08 | 4,153 | 4,158 | 4,102 | 4,136 | -28 | -0.7% | 153,500 |
| 2024/02/07 | 4,150 | 4,172 | 4,132 | 4,164 | ±0 | ±0% | 119,700 |
| 2024/02/06 | 4,206 | 4,206 | 4,158 | 4,164 | -68 | -1.6% | 113,400 |
| 2024/02/05 | 4,213 | 4,244 | 4,194 | 4,232 | +17 | +0.4% | 108,700 |
| 2024/02/02 | 4,209 | 4,225 | 4,189 | 4,215 | +34 | +0.8% | 98,600 |
| 2024/02/01 | 4,191 | 4,207 | 4,161 | 4,181 | -35 | -0.8% | 114,800 |
| 2024/01/31 | 4,168 | 4,220 | 4,159 | 4,216 | +26 | +0.6% | 109,000 |
| 2024/01/30 | 4,252 | 4,252 | 4,190 | 4,190 | -27 | -0.6% | 99,500 |
| 2024/01/29 | 4,211 | 4,234 | 4,196 | 4,217 | +6 | +0.1% | 80,300 |
| 2024/01/26 | 4,193 | 4,240 | 4,191 | 4,211 | +13 | +0.3% | 111,600 |
| 2024/01/25 | 4,190 | 4,213 | 4,161 | 4,198 | -13 | -0.3% | 90,600 |
| 2024/01/24 | 4,201 | 4,228 | 4,167 | 4,211 | +10 | +0.2% | 155,200 |
| 2024/01/23 | 4,217 | 4,260 | 4,181 | 4,201 | -20 | -0.5% | 153,200 |
| 2024/01/22 | 4,147 | 4,225 | 4,125 | 4,221 | +46 | +1.1% | 214,800 |
| 2024/01/19 | 4,250 | 4,262 | 4,147 | 4,175 | -91 | -2.1% | 307,700 |
| 2024/01/18 | 4,301 | 4,325 | 4,266 | 4,266 | -105 | -2.4% | 223,200 |
| 2024/01/17 | 4,365 | 4,450 | 4,360 | 4,371 | -2 | ±0% | 203,900 |
| 2024/01/16 | 4,472 | 4,480 | 4,363 | 4,373 | -107 | -2.4% | 215,500 |
| 2024/01/15 | 4,468 | 4,506 | 4,415 | 4,480 | +34 | +0.8% | 197,700 |
| 2024/01/12 | 4,563 | 4,593 | 4,383 | 4,446 | -116 | -2.5% | 711,000 |
| 2024/01/11 | 4,566 | 4,590 | 4,513 | 4,562 | +56 | +1.2% | 239,600 |
| 2024/01/10 | 4,435 | 4,525 | 4,426 | 4,506 | +104 | +2.4% | 283,000 |
| 2024/01/09 | 4,404 | 4,409 | 4,367 | 4,402 | +49 | +1.1% | 131,100 |
| 2024/01/05 | 4,453 | 4,453 | 4,343 | 4,353 | -60 | -1.4% | 164,000 |
| 2024/01/04 | 4,330 | 4,415 | 4,282 | 4,413 | +102 | +2.4% | 78,100 |
| 2023/12/29 | 4,335 | 4,360 | 4,279 | 4,311 | -24 | -0.6% | 124,000 |
| 2023/12/28 | 4,313 | 4,364 | 4,313 | 4,335 | -2 | ±0% | 76,400 |
| 2023/12/27 | 4,273 | 4,346 | 4,257 | 4,337 | +53 | +1.2% | 124,100 |
| 2023/12/26 | 4,283 | 4,323 | 4,263 | 4,284 | -35 | -0.8% | 116,000 |
| 2023/12/25 | 4,324 | 4,342 | 4,290 | 4,319 | +23 | +0.5% | 134,000 |
| 2023/12/22 | 4,247 | 4,300 | 4,246 | 4,296 | +49 | +1.2% | 141,400 |
| 2023/12/21 | 4,274 | 4,297 | 4,231 | 4,247 | -34 | -0.8% | 152,100 |
| 2023/12/20 | 4,360 | 4,385 | 4,281 | 4,281 | -82 | -1.9% | 209,500 |
| 2023/12/19 | 4,404 | 4,422 | 4,341 | 4,363 | -48 | -1.1% | 148,100 |
| 2023/12/18 | 4,408 | 4,436 | 4,375 | 4,411 | -56 | -1.3% | 151,700 |
| 2023/12/15 | 4,530 | 4,536 | 4,454 | 4,467 | -97 | -2.1% | 210,600 |
| 2023/12/14 | 4,595 | 4,614 | 4,534 | 4,564 | -16 | -0.3% | 99,600 |
| 2023/12/13 | 4,600 | 4,622 | 4,574 | 4,580 | -11 | -0.2% | 109,700 |
| 2023/12/12 | 4,607 | 4,648 | 4,591 | 4,591 | -7 | -0.2% | 122,900 |
| 2023/12/11 | 4,610 | 4,618 | 4,549 | 4,598 | +4 | +0.1% | 143,800 |
| 2023/12/08 | 4,590 | 4,618 | 4,577 | 4,594 | -6 | -0.1% | 153,400 |
51～
100
件表示中 / 3451件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 久光薬 | 383,500円 | +7.3% | -3.8% | 2.35% | 18.38倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ロート | 314,600円 | +14.0% | +16.7% | 0.86% | 23.92倍 | 3.09倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| 参天薬 | 154,800円 | +8.2% | - | 2.13% | 19.06倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| 日本新薬 | 441,300円 | +2.0% | +11.5% | 2.81% | 11.43倍 | 1.41倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 369,200円 | +8.5% | -4.5% | 1.90% | 17.30倍 | 1.06倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム
